Weighing the Evidence: The Challenge of Developing Evidence-Based Renal Dosing Strategies

Chronic kidney disease and drug dosing: information for providers (revised Jan 2010). Estimation of Kidney Function for Prescription Medication Dosage in Adults. National Kidney Disease Education Program. http://www.nkdep.nih.gov/professionals/drug-dosing-information.htm.

Bertino J.S. Jr. Measured versus estimated creatinine clearance in patients with low serum creatinine values [erratum appears in Ann Pharmacother. 1994; 28(6): 811]. Ann Pharmacother. 1993; 27(12): 1439–1442.

Demirovic J.A. , Pai A.B. , Pai M.P. Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharm. 2009; 66(7): 642–648.

Smythe M. , Hoffman J. , Kizy K. , Dmuchowski C. Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. Am J Hosp Pharm. 1994; 51(2): 198–204.

Stevens L.A. , Nolin T.D. , Richardson M.M. ; Chronic Kidney Disease Epidemiology Collaboration. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis. 2009; 54(1): 33–42.

Creatinine standardization recommendations. National Kidney Disease Education Program. June 30, 2010. http://www.nkdep.nih.gov/labprofessionals/Clinical_Laboratories.htm.

Guidance for industry. Pharmacokinetics in patients with impaired renal function — study design, data analysis, and impact on dosing and labeling (May 1998). US Food and Drug Administration. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072127.pdf.

Draft guidance. Guidance for industry. Pharmacokinetics in patients with impaired renal function — study design, data analysis, and impact on dosing and labeling (March 2010). US Food and Drug Administration. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM204959.pdf.

US News & World Report. Best hospitals. http://health.usnews.com/best-hospitals.